Dorsavi Ltd
dorsaVi Ltd is focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety.
The business
dorsaVi Ltd is focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Video AI, ViMove+, ViSafe+, and Research+. Video AI products provide rapid movement assessment and instant reporting. ViSafe+ offers a range of solutions designed to enhance workplace safety and reduce injuries through ergonomic risk assessment software. ViMove+ equips clinics and sports professionals with advanced movement analysis technology, using wearable sensors and biomechanical assessment tools for precise, real-time tracking of client and athlete movements. Research+ is a product designed for research professionals who demand precision motion capture and third dimensional (3D) biomechanics analysis in their work. Its wearable sensor technology enables many aspects of detailed human movement and position to be captured, quantified, and assessed.
Small Caps Research
No research on Dorsavi Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise DVL based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
dorsaVi’s RRAM Reflex Platform Achieves Breakthrough in Robotic Speed and Intelligence
dorsaVi (ASX: DVL) has achieved a technical breakthrough in the evaluation of its robotic RRAM reflex platform, demonstrating that memory is no longer the bottleneck in achieving biological-grade reflexes. The platform has shown itself capable of delivering high-level reflexes faster than the human nervous system with minimal energy use. Testing also confirmed that intelligence is no […]
dorsaVi Unveils Artemis Labs Platform for Next-Generation Sensor Technologies
dorsaVi (ASX: DVL) has launched Artemis Labs, a wholly owned subsidiary focused on advancing robotics, artificial intelligence and sensor technologies. The new division will merge dorsaVi’s FDA-cleared movement analytics with resistive random-access memory (RRAM) technology licensed from Nanyang Technological University in Singapore. The company sees Artemis Labs acting as an innovation hub to extend human […]
dorsaVi Confirms Suitability of RRAM Technology for Wearable AI-Driven Sensors
An internal assessment of dorsaVi’s (ASX: DVL) resistive random access memory (RRAM) technology has confirmed its suitability for high-speed, low-power usage in embedded, wearable and AI-driven devices. Head-to-head comparisons with industry peers at the 40 nanometer (nm) node demonstrated the technology could offer highly-competitive speed, retention and endurance metrics. High-speed performance with up to 200 […]
dorsaVi Initiates Real-World RRAM Sensor Testing in Singapore’s Biomedical Space
Motion analysis device developer dorsaVi (ASX: DVL) has delivered its resistive random-access memory (RRAM)-powered sensor systems to Singapore for comprehensive testing in real-world biomedical contexts. Testing will focus on edge-device functionality under realistic conditions in applications where traditional NAND flash memory has struggled to meet the write demands of biosignal applications, creating bottlenecks for wearable […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.